Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03271047
Title Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Array BioPharma
Indications

colorectal cancer

Therapies

Binimetinib + Ipilimumab + Nivolumab

Binimetinib + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.